Puma Biotechnology Stock Analysis

Puma Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Puma Biotechnology was at this time reported as 2.29. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Puma Biotechnology had not issued any dividends in recent years. Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company was founded in 2010 and is headquartered in Los Angeles, California. Puma Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 196 people. To find out more about Puma Biotechnology contact Alan Auerbach at 424 248 6500 or learn more at https://www.pumabiotechnology.com.

Puma Biotechnology Investment Alerts

Puma Biotechnology Upcoming and Recent Events

Puma Largest EPS Surprises

View All Earnings Estimates

Puma Biotechnology Environmental, Social, and Governance (ESG) Scores

Puma Biotechnology Thematic Classifications

Puma Stock Institutional Investors

Note, although Puma Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Puma Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 295.29 M.

Puma Profitablity

The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Management Efficiency

Puma Biotechnology has return on total asset (ROA) of 0.099 % which means that it generated a profit of $0.099 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3969 %, meaning that it created $0.3969 on every $100 dollars invested by stockholders. Puma Biotechnology's management efficiency ratios could be used to measure how well Puma Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. The Puma Biotechnology's current Return On Tangible Assets is estimated to increase to 0.20. The Puma Biotechnology's current Return On Capital Employed is estimated to increase to 0.28. As of now, Puma Biotechnology's Debt To Assets are increasing as compared to previous years. The Puma Biotechnology's current Fixed Asset Turnover is estimated to increase to 47.51, while Total Assets are projected to decrease to under 168.9 M.

Technical Drivers

As of the 15th of December 2025, Puma Biotechnology holds the Risk Adjusted Performance of 0.0839, semi deviation of 4.2, and Coefficient Of Variation of 928.26. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Puma Biotechnology, as well as the relationship between them.

Puma Biotechnology Price Movement Analysis

Puma Biotechnology Insider Trading Activities

Puma Biotechnology Outstanding Bonds

Puma Biotechnology Predictive Daily Indicators

Puma Biotechnology Corporate Filings

Puma Biotechnology Forecast Models

Puma Biotechnology's time-series forecasting models are one of many Puma Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Puma Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Puma Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Puma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Puma Biotechnology. By using and applying Puma Stock analysis, traders can create a robust methodology for identifying Puma entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Puma analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Puma analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Puma Biotechnology stock analysis indicators help investors evaluate how Puma Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Puma Biotechnology shares will generate the highest return on investment. By understating and applying Puma Biotechnology stock analysis, traders can identify Puma Biotechnology position entry and exit signals to maximize returns.

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.